RET-Positive Metastatic NSCLC

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

RET-Positive Metastatic NSCLC

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

10 seconds

Playback speed

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

WCLC 2022 on the Phase 3 SANOVO Study: Savolitinib or Placebo in Combination With Osimertinib in EGFRm and MET Overexpressed NSCLC

By WCLC 2022 Conference Coverage FEATURING Qing Zhou

171 views

August 18, 2022

Comments 0

Biomarkers in Thyroid Cancer: Endocrinologist's Perspective

Priyanka Iyer

497 views

Molecular Markers in Thyroid Cancer from the Endocrinologist's Persp…

Yale School of Medicine

E. Holt

1.3K views

Selpercatinib in RET Fusion-Positive mNSCLC: Achievements and Gray A…

Lorenzo Belluomini

1.1K views

Lecture Summary - Selpercatinib in RET Fusion-Positive mNSCLC: Achie…

Lorenzo Belluomini

760 views

Rebiopsy and cfDNA in a Complex and Changing NSCLC Landscape

Nicola Normanno

94 views

The Role of Chemotherapy in Driver Positive NSCLC

GRACE

J. Weiss

48 views

Targeted Therapies in Oligo-Metastatic NSCLC

GRACE

T. Leal

46 views

ASCO 2022 on IO and Chemo-IO for NSCLC With Novel Actionable Oncogen…

ASCO 2022 Conference Coverage

L. Mazzeo, M. Occhipinti

186 views

ASCO 2022 on Durvalumab +/- Tremelimumab + Chemo in 1L mNSCLC: AE Ma…

ASCO 2022 Conference Coverage

B. Chul Cho

61 views

Lecture Summary - ASCO 2022 on Durvalumab +/- Tremelimumab + Chemo i…

ASCO 2022 Conference Coverage

B. Chul Cho

15 views

WCLC 2022 on the NADIM II Trial: Pre-Treatment ctDNA Levels Signific…

WCLC 2022 Conference Coverage

A. Romero

93 views

WCLC 2022 on 1L Chemotherapy vs. Chemoimmunotherapy in Stage IV LCNE…

WCLC 2022 Conference Coverage

L. Meng

86 views

Lecture Summary - WCLC 2022 on 1L Chemotherapy vs. Chemoimmunotherap…

WCLC 2022 Conference Coverage

L. Meng

10 views

WCLC 2022 on KEYNOTE B36: A Pilot Study of 1L Tumor Treating Fields …

WCLC 2022 Conference Coverage

R. Kotecha

73 views

Lecture Summary - WCLC 2022 on KEYNOTE B36: A Pilot Study of 1L Tumo…

WCLC 2022 Conference Coverage

R. Kotecha

14 views

Intraoperative Molecular Imaging Guided Resection of CEACAM5+ Lung T…

Feredun Azari

22 views

Lecture Summary - Intraoperative Molecular Imaging Guided Resection …

Feredun Azari

10 views

WCLC 2022 on Socio-Economic Inequalities in NSCLC Treatment During t…

WCLC 2022 Conference Coverage

R. Norris

39 views

Lecture Summary - WCLC 2022 on Socio-Economic Inequalities in NSCLC …

WCLC 2022 Conference Coverage

R. Norris

84 views

WCLC 2022 on the Phase II DOLPHIN Study: Durvalumab + Concurrent RT …

WCLC 2022 Conference Coverage

M. Tachihara

73 views

ESMO 2022 on the Results of the Randomized DICIPLE Phase 3 Trial: Ni…

ESMO 2022 Conference Coverage

G. Zalcman

1.1K views

Lecture Summary - ESMO 2022 on the Results of the Randomized DICIPLE…

ESMO 2022 Conference Coverage

G. Zalcman

19 views